Antagonism of interleukin 17 protects chronic obstructive pulmonary disease rat lungs from adverse effects of environmental PM

Haitao Li, Xixin Yan, Shan Feng, Shuai Li, Huiran Zhang, Jingwen Li, Tianjie Qi

Abstract read

In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Particulate matter-induced epigenetic modifications and lung complications.European respiratory review : an official journal of the European Respiratory Society · 2024
Review
Effect of air pollution on asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024
Review
In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408.International journal of chronic obstructive pulmonary disease · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haitao LiDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Xixin YanDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Shan FengDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Shuai LiDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Huiran ZhangDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Jingwen LiDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Tianjie QiDepartment of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University No. 215, Heping West Road, Shijiazhuang 050000, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe air pollution has raised concerns about the adverse effects of particulate matters 2.5 μm in size (PM

Indexed as

COPD modelEnvironmental PM2.5IL-17 antibodyinflammatory factorslung impairment

Identifiers

PMID33042460

PMCPMC7540087

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.